Imagion Biosystems Begins Clinical Studies on MagSense Particles for Cancer Detection
Imagion Biosystems is progressing to clinical studies of the efficacy of its MagSense magnetic particles for early detection of cancer, marking an important advancement for the Melbourne biotech firm that is pioneering the application of magnetic particles beyond […]